Multispecific anti-HIV duoCAR-T cell therapy mediates robust HIV suppression and elimination of HIV-infected cells in humanised mice

Multispecific anti-HIV duoCAR-T cell therapy mediates robust HIV suppression and elimination of HIV-infected cells in humanised mice

Bibliographic Details
Main Authors:	K. Anthony-Gonda, A. Bardhi, A. Ray, W. Krueger, D. Schneider, Z. Zhu, R. Orentas, D. Dimitrov, H. Goldstein, B. Dropulic
Format:	Article
Language:	English
Published:	Elsevier 2019-12-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020301965

Similar Items

Evaluation of the in vivo capacity of broadly neutralising anti-HIV antibodies to eliminate latently infected cells from HIV-infected individuals using a novel humanised mouse model
by: N. Flerin, et al.
Published: (2017-12-01)

Improved HIV-1 clearance with BIT225 in the HIV-1 infected humanised mouse model
by: J. Wilkinson, et al.
Published: (2017-12-01)

O4 Spatial distribution of HIV in antiretroviral-treated humanised mice
by: Virginie Fievez, et al.
Published: (2016-09-01)

Clearance of HIV infection by selective elimination of host cells capable of producing HIV
by: Min Li, et al.
Published: (2020-08-01)

Engineering CAR T Cells to Target the HIV Reservoir
by: Wenli Mu, et al.
Published: (2020-08-01)

μ-Lat: a high-throughput humanised mouse model of latent HIV infection
by: H. Sperber, et al.
Published: (2019-12-01)

Author Correction: Clearance of HIV infection by selective elimination of host cells capable of producing HIV
by: Min Li, et al.
Published: (2020-12-01)

HIV-TB the deadly duo, the biggest health challenge in Fiji
by: Muller Santhakumari, et al.
Published: (2012-05-01)

Advances in Developing CAR T-Cell Therapy for HIV Cure
by: Jinxin Qi, et al.
Published: (2020-03-01)

Elimination of HIV-1-infected cells by broadly neutralizing antibodies
by: Timothée Bruel, et al.
Published: (2016-03-01)

Challenges and opportunities for T cell-mediated strategies to eliminate HIV reservoirs
by: Mark Alan Brockman, et al.
Published: (2015-10-01)

Alemtuzumab-induced elimination of HIV-1-infected immune cells
by: Kiat Ruxrungtham, et al.
Published: (2016-01-01)

DNA‐Mediated Assembly of Multispecific Antibodies for T Cell Engaging and Tumor Killing
by: Liqiang Pan, et al.
Published: (2020-01-01)

Stem cell–derived CAR T cells traffic to HIV reservoirs in macaques
by: Isaac M. Barber-Axthelm, et al.
Published: (2021-01-01)

Can pediatric HIV be eliminated?
by: G. Gray
Published: (2014-04-01)

Multispecific resistance of sheep trichostrongylids in Austria
by: Untersweg Florian, et al.
Published: (2021-01-01)

Pre-clinical data supporting immunotherapy for HIV using CMV-HIV-specific CAR T cells with CMV vaccine
by: Blanchard, M.S, et al.
Published: (2022)

Safety of pediatric HIV elimination: the growing population of HIV- and antiretroviral-exposed but uninfected infants.
by: Lynne M Mofenson, et al.
Published: (2014-04-01)

Elimination of HIV-1/SHIV infected cells by combinations of bispecific HIV x CD3 DART® molecules
by: M. Tuyishime, et al.
Published: (2019-12-01)

Specific Elimination of Latently HIV-1 Infected Cells Using HIV-1 Protease-Sensitive Toxin Nanocapsules.
by: Jing Wen, et al.
Published: (2016-01-01)

Recent Advances in the Molecular Design and Applications of Multispecific Biotherapeutics
by: Xiaotian Zhong, et al.
Published: (2021-03-01)

CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV
by: Gloria B. Kim, et al.
Published: (2019-09-01)

HIV-1-Specific CAR-T Cells With Cell-Intrinsic PD-1 Checkpoint Blockade Enhance Anti-HIV Efficacy in vivo
by: Zhengtao Jiang, et al.
Published: (2021-07-01)

Toward T Cell-Mediated Control or Elimination of HIV Reservoirs: Lessons From Cancer Immunology
by: Geetha Mylvaganam, et al.
Published: (2019-09-01)

26 Towards an HIV functional cure with CAR-T cells: elucidating mechanisms underlying the extremely high potency of bispecific anti-HIV CARs designed for optimal activity and minimal immunogenicity
by: M.H. Ghanem, et al.
Published: (2017-07-01)

Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes.
by: Richard Brad Jones, et al.
Published: (2014-08-01)

Histone Deacetylase Inhibitors Impair the Elimination of HIV-Infected Cells by Cytotoxic T-Lymphocytes
by: Jones, Richard Bradley, et al.
Published: (2014)

Toward Drug-Like Multispecific Antibodies by Design
by: Manali S. Sawant, et al.
Published: (2020-10-01)

Engineered Technologies and Bioanalysis of multispecific Antibody Formats
by: Marta Amaral, et al.
Published: (2020-01-01)

The art of HIV elimination: past and present science
by: Lwuji, C.C, et al.
Published: (2015)

Virological impact of HCV elimination with DAAs in the HIV reservoir in HIV/HCV patients
by: M. Coiras, et al.
Published: (2019-12-01)

Trends in undiagnosed HIV prevalence in England and implications for eliminating HIV transmission by 2030: an evidence synthesis model
by: Anne M Presanis, PhD, et al.
Published: (2021-10-01)

Elimination of HIV-1-Infected Primary T Cell Reservoirs in an In Vitro Model of Latency.
by: Stephen A Rawlings, et al.
Published: (2015-01-01)

Expression of humanised antibodies in mammalian and insect cells
by: Bentley, Kathryn Jane
Published: (1995)

Editorial: Exploring Novel Approaches to Eliminate HIV Reservoirs to Achieve a Cure for HIV
by: Renée M. van der Sluis, et al.
Published: (2021-02-01)

Tradeoff between stability and multispecificity in the design of promiscuous proteins.
by: Menachem Fromer, et al.
Published: (2009-12-01)

Experience in eliminating vertical HIV transmission in Evinayong
by: Yatson Jesús Sánchez Cabrera, et al.
Published: (2017-06-01)

The road to eliminate mother‐to‐child HIV transmission
by: Andrew M. Redmond, et al.
Published: (2015-11-01)

Barriers to eliminating HIV transmission in England by 2030
by: Brooke E Nichols, et al.
Published: (2021-10-01)

WAYS TO ELIMINATION OF MOTHER-TO-CHILD TRANSMISSION OF HIV
by: N. V. Kozyrina, et al.
Published: (2018-12-01)